First batch of Russia’s Sputnik V vaccine to arrive in India by May 1 | Latest News India - Hindustan Times
close_game
close_game

First batch of Russia’s Sputnik V vaccine to arrive in India by May 1

ByLeroy Leo, New Delhi
Apr 28, 2021 02:16 AM IST

“The first doses will be delivered on 1 May,” RDIF chief executive officer Kirill Dmitriev said.

The Russian Direct Investment Fund (RDIF) on Tuesday said it will export the first batch of Sputnik V vaccine to India from May 1, the day India expands its Covid-19 immunisation drive to cover all adults.

A medical specialist holds a vial of Sputnik V vaccine against the coronavirus in a department store in Moscow, Russia, January 18, 2021.(Reuters)
A medical specialist holds a vial of Sputnik V vaccine against the coronavirus in a department store in Moscow, Russia, January 18, 2021.(Reuters)

“The first doses will be delivered on 1 May,” RDIF chief executive officer Kirill Dmitriev said.

HT launches Crick-it, a one stop destination to catch Cricket, anytime, anywhere. Explore now!

However, a spokesperson for the company’s partner in India, Dr Reddy’s Laboratories, said it is not providing a specific date for the launch, adding that while the company had earlier indicated that delivery will start from the end of May, that timeline has now been shifted to anytime in May.

“Discussions over pricing and the number of doses are still ongoing between Dr Reddy’s, RDIF and the government,” the spokesperson said.

RDIF had last year said that the company will price the vaccine at less than $10 ( 750) per dose in international markets. Pricing of the vaccine varies in different countries.

Dr Reddy’s management has earlier said that the initial quantity of vaccine that will be supplied in India will be limited as they will primarily be imported from Russia. However, RDIF’s manufacturing partners in India will start producing the jabs locally by July, after which the supplies will be scaled up.

RDIF is in partnership with six companies in India— Hetero Biopharma, Gland Pharma, Stelis Biopharma, Panacea Biotec, Virchow Biotech and Shilpa Medicare—to collectively contract manufacture more than 850 million doses of Sputnik V. Dr Reddy’s pact with RDIF is for supply of 250 million doses. Supply of the vaccine is crucial for meeting the increased demand when vaccination will be opened up for adults from Saturday.

Discover the complete story of India's general elections on our exclusive Elections Product! Access all the content absolutely free on the HT App. Download now!

Get Current Updates on India News, Ram Navami Live Updates , Lok Sabha Election 2024 live, Elections 2024, Election 2024 Date along with Latest News and Top Headlines from India and around the world.
SHARE THIS ARTICLE ON
Share this article
SHARE
Story Saved
Live Score
OPEN APP
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Wednesday, April 17, 2024
Start 14 Days Free Trial Subscribe Now
Follow Us On